Dr. P K Das

Dr. P K Das

Senior Consultant 

33 Years of Experience

Medical Oncologist

MBBS, MD, DM, Fellowship

Reg. No.:22332, Delhi Medical Council

Indraprastha Apollo Hospital, New Delhi

English

Consultation Fee ₹ 2000

Book an Appointment

About Dr. P K Das

  • Dr. P.K. Das is a highly regarded Medical Oncologist based in Delhi, India, with 33 years of experience specializing in oncology and hematology.
  • His primary areas of interest within oncology include blood cancers, breast cancer, lung cancer, brain tumors, and gynecological cancers.
  • His educational background includes an MBBS from Sambalpur University, 1991, MD in General Medicine from Berhampur University, 1995, DM in Medical Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi, 2000, and a Fellowship in Hematology-oncology from Peter-Mac Cancer Centre, Melbourne, Australia.
  • Throughout his career, Dr. Das has actively contributed to research endeavors, treated numerous cancer patients, and participated in innovative cancer treatment approaches.
  • He is dedicated to education and has mentored both nursing staff and doctors while also organizing cancer screening and awareness camps.
  • Additionally, he is passionate about promoting health and fitness, often serving as a motivational speaker on cancer awareness and the role of exercise in cancer prevention and treatment.
  • Dr. Das has authored multiple papers on various cancer types, with a focus on providing deeper insights into cancer and aiding a broader audience.
  • He is a member of the Indian Society of Medical & Pediatric Oncology (ISMPO), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO).

Book Your Appointment With Dr. P K Das

Get a Treatment Plan Within 1 Hour

Education

  • MBBS, Sambalpur University, 1991
  • MD (General Medicine), Berhampur University, 1995
  • DM (Medical Oncology), All India Institute of Medical Sciences, New Delhi, 2000
  • Fellowship (Hematology-oncology), Peter-Mac Cancer Centre, Melbourne, Australia

Past Experience

  • Academic Coordinator, Apollo Cancer Institute, New Delhi
  • Visiting Senior Consultant, RAK Hospital, UAE
  • Visiting Senior Consultant, Apollo Hospital, Bhubaneswar

Awards

  • Nominated for the Medical Excellence Award for excellence in the field of Oncology in India by Harvard Medical International Community Service (From Harvard Medical School).

Associations/Membership

  • Indian Society of Medical & Paediatric Oncology (ISMPO)
  • European Society of Medical Oncology (ESMO)
  • American Society of Clinical Oncology (ASCO)

Paper Published

  • Disseminated fungal infection complicated with pulmonary haemorrhage in a case of acute myeloid leukaemia: A case report published in Postgraduate Medical Journal 2000 Vol 76, Pg 704-709.
  • Extrosseous Ewing's sarcoma of the kidney: A case report published in Urologic Internationals in June 2001
  • Analysis of risk factors and cytogenetic anomalies in North Indian Leukemia Patients- Accepted for Publication in Indian Journal of Medical Research in Oct 2005.
  • Brain Tumor and Gliadel wafer treatment: Published in Indian Journal of Cancer, Panigrahi M, DAS PK et al. Jan-March 2011/volume 48, Issue 1/ page 11-17.
  • Fibro lamellar Carcinoma of the liver in an elderly patient: A unique Case report- Dr. P.K.Das, Dr. M. Bhadauria – accepted for publication in Indian Journal of Cancer.
  • Lapatinib Use for Brain Metastases in HER 2- Positive Metastatic Breast Cancer : ( Abstract:167).
  • A case report Published in –the Oncologist, Aug 2010, pages 127-129.
  • Two cases of NK/T cell Lymphoma presenting as Chronic Rhino sinusitis: Published in Indian Journal of Hematology and Blood Transfusion, July 2016, pages 21-28.
  • Cetuximab in the treatment of a patient with head and neck cancer with Squamous cell carcinoma: A case report published in July 2016 (Case report in oncological medicine).
  • Primary renal cell lymphoma: Case report and suggestions for diagnosis and management. Published in July 2016 (Indian Journals of hematology and blood transfusion).
  • Epidemiological study to evaluate the prevalence of epidermal growth factor receptor (EGFR) mutation status in NSCLC in India. Published (Asian Journal of Oncology).
  • Reliability of 18F- FDG PET metastatic parameters in simultaneous PET /MRI in prognostication of invasive ductal carcinoma: A feasibility study. Publication American Journal of Roentgenology in September 2017.
  • Evaluation of Chemotherapy response in locally advanced breast Cancer with simultaneous PET/MRI using pharmacokinetic, semi Quantitative and metabolic parameters. Publication in European Journal of Radiology in July 2018.

Field of Expertise

  • Adrenal Cancer Treatment
  • Benign and Cancerous Tumor Excision
  • Bile Duct Cancer Treatment
  • Brain Tumor Surgery
  • Breast Biopsy
  • CAR T-Cell Therapy
  • Carcinoid Tumor Treatment
  • Castleman Disease Treatment
  • Chemotherapy
  • Colon Cancer Surgery
  • Completion Thyroidectomy
  • D2 Gastrectomy
  • Endometrial Biopsy
  • Endometrial Cancer Treatment
  • Endoscopic Tumor Removal
  • Ewing Family of Tumors Treatment
  • Fine Needle Aspiration
  • Genitourinary Cancer Treatment
  • Gestational Trophoblastic Disease (GTD) Treatment
  • Hormone Therapy
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Image-Guided Radiation Therapy (IGRT)
  • Immunotherapy
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Kaposi Sarcoma Treatment
  • Lobectomy
  • Lumpectomy
  • Malignant Mesothelioma Treatment
  • Metastatic Tumor Treatment
  • Microsurgical Tumor Removal
  • Minimally Invasive Cancer Surgery
  • Mohs Surgery
  • Nasal Cavity and Paranasal Sinus Cancer Treatment
  • Nasopharyngeal Cancer Treatment
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Oncological Surgery
  • Ovarian Biopsy
  • Pap Smear
  • Papillary Thyroid Cancer Treatment
  • Penile Cancer Treatment
  • PET CT Scan
  • Proton Therapy
  • Radiation Therapy
  • Radioisotope Therapy
  • Rhabdomyosarcoma (RMS) Treatment
  • Robotic Cancer Surgery
  • Skin Lymphoma Treatment
  • Small Intestine Cancer Treatment
  • Targeted Therapy
  • Thymectomy
  • Thymoma and Thymic Carcinoma Treatment
  • Transarterial Chemoembolization (TACE)
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment
  • Whipple Procedure
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia (AML)
  • Acute Promyelocytic Leukemia (APL)
  • Adenocarcinoma
  • Adenosquamous Carcinoma
  • Adnexal Tumor
  • Adrenocortical Carcinoma
  • Adult Hodgkins Lymphoma
  • AIDS-Related Cancer
  • Ameloblastoma
  • Anal Cancer
  • Anaplastic Carcinoma
  • Appendix Cancer
  • Astrocytoma
  • Atypical Hyperplasia
  • Atypical Spindle Cell Tumor
  • Atypical Teratoid/Rhabdoid Tumor (ATRT)
  • Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
  • Basal Cell Carcinoma (BCC)
  • Basal Cell Carcinoma of the Skin
  • Benign Bone Tumors
  • Benign Hematology
  • Benign Lung Tumors
  • Benign Soft Tissue Tumors
  • Bile Duct Cancer, Stones, & Strictures
  • Blood Cancer
  • Bone Cancer
  • Bone Marrow Cancer
  • Brain Stem Glioma
  • Breast Cancer
  • Breast Cancer During Pregnancy
  • Breast Cancer Recurrence
  • Bronchial Tumors
  • Burkitt Lymphoma
  • Cancer in Children
  • Carcinoid Syndrome
  • Carcinoid Tumor (Gastrointestinal)
  • Carcinoid Tumors of the Lungs
  • Cervical Cancer
  • Childhood Acute Lymphoblastic Leukemia
  • Cholangiocarcinoma
  • Chordomas
  • Chronic Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelogenous Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Chronic Myeloproliferative Neoplasms
  • Giant Cell Tumor
  • Hemangiopericytoma
  • Hodgkin Lymphoma
  • Malignant Peripheral Nerve Sheath Tumor (MPNST)
  • Mediastinal Teratoma
  • Nasal Cancer
  • Nasopharyngeal Angiofibroma
  • Olfactory Neuroblastoma
  • Optic Nerve Glioma
  • Paranasal Tumor
  • Pediatric Spinal Tumor
  • Pigmented Villonodular Synovitis (PVNS)
  • Polycythemia Vera
  • Sacrococcygeal Teratoma (SCT)
  • Tarlov Cysts